Key statistics
On Wednesday, Vir Biotechnology Inc (VIR*:MEX) closed at 170.00, 0.00% below its 52-week high of 170.00, set on Feb 25, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 170.00 |
|---|---|
| High | 170.00 |
| Low | 170.00 |
| Bid | -- |
| Offer | -- |
| Previous close | 170.00 |
| Average volume | 34.00 |
|---|---|
| Shares outstanding | 157.12m |
| Free float | 142.67m |
| P/E (TTM) | -- |
| Market cap | 1.43bn USD |
| EPS (TTM) | -3.16 USD |
Data delayed at least 20 minutes, as of Feb 25 2026 11:30 GMT.
More ▼
Press releases
- Vir Biotechnology to Participate in Upcoming Investor Conferences
- Vir Biotechnology Announces Pricing of Public Offering of Common Stock
- Vir Biotechnology Announces Proposed Public Offering of Common Stock
- Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results
- Vir Biotechnology Reports Positive Updated Phase 1 Results for PSMA-targeting, PRO-XTEN® Dual-masked T-Cell Engager VIR-5500 in Patients with Metastatic Prostate Cancer
- Vir Biotechnology to Host Conference Call for Fourth Quarter and Full Year 2025 Financial Results
- Vir Biotechnology Provides Updates on Chronic Hepatitis Delta and Oncology Programs and Upcoming 2026 Clinical Milestones
- Vir Biotechnology to Present at the 44th Annual J.P. Morgan Healthcare Conference
- Vir Biotechnology Grants Norgine Exclusive Commercial License to Chronic Hepatitis Delta Treatment Candidate in Europe, Australia & New Zealand, Including Global Cost Sharing Agreement for Ongoing ECLIPSE Clinical Development Program
More ▼
